Diabetes Testing Centers™
Chronic Disease
Screening &
Assessments
Screen. Test. Treat.
TriageIQ™ | Universal Chronic Screener. Every Adult.
Diabetes Testing Centers™
Chronic Disease
Screening &
Assessments
Screen. Test. Treat.
Healthcare organizations can become licensed Diabetes Testing Centers™ partners to screen, test, and treat chronic disease risks through rapid, non-invasive, billable workflows.
Diabetes Testing Centers™ (DTC) began with a focus on diabetes-related damage detection and has expanded into a broader chronic risk assessment platform for adult primary care, specialty clinics, MSOs, ACOs, and healthcare organizations.
DTC was founded by former family practice owners who saw firsthand how often chronic risks are identified too late, after preventable complications have already begun. That experience, combined with enterprise healthcare leadership in diagnostics and diabetes, shaped DTC’s development of scalable, non-invasive, billable point-of-care programs. Today, with access to a national network of more than 20,000 independent practices, DTC helps CMS-ready and cash-pay providers identify patient risks during the same visit through rapid, objective chronic risk screeners and assessments.
Early Risk Signals
Most chronic diseases do not begin with a diagnosis. They often begin years earlier with subtle changes in how a patient feels, functions, or moves — changes that may not appear in labs and may never become documented concerns. Patients often notice these changes but explain them away as aging, stress, fatigue, or “just getting older.” They may not schedule a visit, mention them during an existing one, or follow up until the symptoms become impossible to ignore. By then, the underlying disease process may have been active for years.
This is the gap structured chronic risk detection is designed to close. Not by adding complexity to the clinical visit, but by creating a systematic mechanism that surfaces what patients are already experiencing at the moment they are already present in the care setting. No additional appointment. No separate referral. No waiting for the patient to decide their symptoms are worth reporting. Healthcare organizations that build detection into the front end of care stop relying on patient-initiated concern as the trigger for clinical action. They capture risk while the patient is in the room, document it while medical necessity is present, and create a pathway forward before the window for early intervention closes. The visit does not change. The clinical intelligence it produces does.
Go Beyond Blood Sugars
The earliest signals emerge in the patient through symptoms, functional change, and subtle clinical patterns that precede what is formally documented in the chart. Adults represent the largest share of the U.S. population and carry the greatest overall burden of chronic disease risk. Adults ages 18–64 make up about 65.0% of this group, while adults 65+ make up about 19.3%. Together, adults 18+ represent about 84.3% of the population measured.
This matters because most chronic conditions become more common, measurable, and clinically actionable during adulthood, such as:
🔎 Population Health Risk. Establishes the patient's baseline risk profile before the encounter begins — determining care pathway and how every downstream signal is interpreted.
❤️ Cardiometabolic Risk. Hypertension, diabetes complications, and vascular disease frequently progress without warning. Early screening reduces the risk of heart attack, stroke, and serious complications.
🧠 Neurological Risk. Silent nerve and brain changes — including cognitive decline, neuropathy, and fall risk — often appear years before symptoms. Early detection allows providers to intervene before irreversible damage occurs.
🧩 Behavioral Risk. Depression, sleep disorders, and behavioral health conditions directly worsen chronic disease outcomes. Early identification enables timely support and coordinated care.
⚡ Pain & Function Risk. In diabetes and other chronic conditions, silent lower-extremity decline may be as important as pain. Routine screening helps identify early risk before instability, ulceration, or amputation.
TriageIQ™ is a proprietary universal adult chronic screener that identifies risk across five domains in about 3 minutes, while supporting medical necessity for further assessment in each domain identified.
Detecting these risks earlier helps protect patients before complications become life-altering. DTC delivers the clinical science behind Chronic Risk Assessments used by specialists nationwide, with flexible onboarding, seamless workflow integration, and the ability to begin generating recurring revenue in under 30 days.*
Identify Patient Signals
The clinical case for earlier testing is not theoretical — it is measurable. Chronic conditions including diabetes, hypertension, peripheral neuropathy, cognitive decline, and cardiovascular disease each follow a predictable trajectory: a long subclinical phase during which damage accumulates silently, followed by a clinical threshold at which intervention becomes reactive rather than preventive. The difference in patient outcomes between detecting a condition during the subclinical phase versus after complications have emerged is significant. So is the difference in cost, complexity, and the range of treatment options still available.
Most primary care workflows are not structured to test during that earlier window. Patients present with a chief complaint. Providers respond to what is reported. What is not reported — early neuropathic changes, subtle cognitive shifts, vascular risk signals, behavioral health burden — is rarely captured because the intake process was not designed to surface it. Testing that could have redirected the clinical pathway simply does not happen.
DTC exists to change that equation. The programs, diagnostics, and workflows DTC brings into a practice are designed specifically to test earlier, within the visits that are already occurring, for the conditions that produce the greatest long-term harm when missed. Earlier testing does not require a different patient. It requires a more structured point of entry into the care that practice is already delivering.
The providers who benefit most are not those adding complexity to their practice. They are those who recognize that the clinical value was already there — in their existing patient panel, at their existing visit frequency — and simply needed a more structured pathway to surface it.
CMS-Ready and Cash-Ready
Aligned with National Guidelines
The guidelines are clear. What is less clear in most busy practices, is how to meet them consistently within existing visit structures without adding staff or extending appointment time.
DPN Signals Other Risks
Every chronic risk domain follows the same logic. Here's how it plays out with neuropathy, one of the earliest and most common complications of diabetes. Annual neuropathy screening, cognitive assessment, depression screening, peripheral arterial disease evaluation, cardiovascular autonomic testing, and diabetic retinopathy imaging each carry their own guideline mandates from CMS, ADA, AHA, and specialty societies. The Annual Wellness Visit creates a structured opportunity to address many of these simultaneously and DTC's programs are built to fulfill them through Cognitive, Behavioral Testing, Balance & Gait Training, Diabetic Neuropathy, Peripheral Arterial Disease Testing, and Diabetic Retinopathy, all non-invasive, point-of-care, and designed to fit within the visit rather than extend it.
DPN warrants specific attention because fiber type determines clinical consequence. Small fiber signals metabolic dysfunction before a single symptom is reported. Large fiber carries loss of protective sensation, the direct pathway to falls, ulcers, and amputation.
Consolidate Patient Care
Start by improving intake — then let the patient signals show you where the biggest clinical and financial opportunities already exist in your practice and get started on testing.
Getting Started Is Simple:
Start with TriageIQ™ at Intake
Use TriageIQ™ as the front door for adult patients to identify early multi-domain risk signals quickly and consistently at the beginning of care.
Identify the Risk Patterns Showing Up in Your Clinic
As intake findings begin to surface patterns, your clinic can see which chronic disease domains are appearing most often and where additional in-house assessment may be most valuable.
Address the Highest-Value Assessments in a 30–60–90 Day Rollout
TriageIQ™ begins creating value at intake immediately. Some patients may warrant targeted next-step assessment right away, while the strongest clinic-wide clinical and financial opportunities typically become clear within the first 30 to 90 days of consistent use:
• 30 days: identify where hidden demand exists
• 60 days: begin focusing on the highest-priority downstream assessments
• 90 days: confirm the most valuable clinical assessments and operational opportunities
Schedule a Meeting to Build Your Rollout Plan. We help you determine the best starting point, review program options, and provide a financial pro forma based on your location, workflow, and payor mix so you can begin implementation with a clear path to deployment.
Start at Intake
"Book a 15‑minute walkthrough” to see how easily DTC programs integrate into your existing workflows.